https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Cumulative small effect genetic markers and the risk of colorectal cancer in Poland, Estonia, Lithuania, and Latvia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28485 Wed 11 Apr 2018 14:12:51 AEST ]]> Lung Cancer Occurrence—Correlation with Serum Chromium Levels and Genotypes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49864 0.1 μg/L were correlated with 73% (52/71) of lung cancers diagnosed with stage I disease. Our findings support the role of chromium and the influence of key proteins on lung cancer burden in the general population.]]> Wed 07 Jun 2023 14:09:37 AEST ]]> Survival of laryngeal cancer patients depending on zinc serum level and oxidative stress genotypes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47243 Tue 10 Jan 2023 15:12:31 AEDT ]]> Blood cadmium levels as a marker for early lung cancer detection https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38391 Mon 29 Jan 2024 18:44:32 AEDT ]]> Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55449 13.6 μg/L) were associated with an increased risk of ovarian cancer (univariable: HR = 3.33; 95% CI: 1.23-9.00; p = 0.02; multivariable: HR = 2.10; 95% CI: 0.73-6.01; p = 0.17). No significant correlation was found with breast cancer risk. High blood lead levels are associated with increased risk of ovarian cancer in BRCA1 carriers, suggesting priority for preventive salpingo-oophorectomy. Potential risk reduction strategies include detoxification. Validation in diverse populations and exploration of detoxification methods for lowering lead levels are required.]]> Mon 03 Jun 2024 08:39:06 AEST ]]> Blood Cadmium Level Is a Marker of Cancer Risk in Men https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55448 0.71 µg/L) had a significantly increased risk of cancer compared to those with low levels (<0.19 µg/L) (HR 3.42, p < 0.001), particularly among non-smokers (HR 3.74, p = 0.003), individuals aged < 60 years (HR 2.79, p = 0.017), and ≥60 (HR 4.63, p = 0.004). The influence of smoking on cancer risk based on Cd levels was not significant in this study. Blood Cd levels may influence cancer risk in men, emphasizing the importance of minimizing Cd exposure to reduce risk. Confirmation of these results in other populations is essential for effective preventive measures against Cd-related cancers.]]> Mon 03 Jun 2024 08:36:29 AEST ]]> Low blood-as levels and selected genotypes appears to be promising biomarkers for occurrence of colorectal cancer in women https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49791 Fri 02 Jun 2023 17:14:07 AEST ]]>